-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Abvc Biopharma, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2011 to 2024.
- Abvc Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $355.000.
- Abvc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2024 was -$111K, a 143% decline from 2023.
- Abvc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $256K, a 67.9% decline from 2022.
- Abvc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $798K, a 3.3% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)